Ástralía - enska - Department of Health (Therapeutic Goods Administration)

alcon laboratories australia pty ltd - cyclopentolate hydrochloride, quantity: 10 mg/ml - eye drops, solution - excipient ingredients: potassium chloride; purified water; hydrochloric acid; benzalkonium chloride; boric acid; disodium edetate; sodium carbonate monohydrate - indications as at 27 june 1996: for mydriasis nad cycloplegia in diagnostic procedures. for some pre- and post-operative states when mydriasis is required and when a shorter acting mydriatic and cycloplegic is needed in the therapy of iridocyclitis.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - travoprost 40 µg/ml;   - eye drops, solution - 40 mcg/ml - active: travoprost 40 µg/ml   excipient: benzalkonium chloride boric acid disodium edetate dihydrate hydrochloric acid mannitol polyethylene glycol hydrogenated castor oil purified water sodium hydroxide trometamol - travatan eye drops are indicated to decrease elevated intraocular pressure in: · ocular hypertension · open-angle glaucoma as monotherapy or as adjunctive therapy.

Ísrael - enska - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - latanoprost - eye drops, solution - latanoprost 50 mcg/ml - latanoprost - latanoprost - reduction of elevated intraocular pressure as a first line treatment in patients with open-angle galucoma and ocular hypertension.

Ísrael - enska - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - latanoprost; timolol as maleate - eye drops, solution - latanoprost 50 mcg/ml; timolol as maleate 5 mg/ml - other antiglaucoma preparations - reduction of intraocular pressure in patients with open angle glaucoma and ocular hypertension who are insufficiently responsive to topical beta-blockers.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - prednisolone acetate 10 mg/ml;   - eye drops, suspension - 1% w/v - active: prednisolone acetate 10 mg/ml   excipient: benzalkonium chloride carbomer 980 sodium acetate trihydrate sodium hydroxide sorbitol water for injection - treatment of steroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - nepafenac, quantity: 3 mg/ml - eye drops, suspension - excipient ingredients: carbomer 974p; carmellose sodium; benzalkonium chloride; boric acid; sodium hydroxide; hydrochloric acid; sodium chloride; propylene glycol; guar galactomannan; purified water; disodium edetate - ilevro is indicated for the:,- prevention and treatment of postoperative pain and inflammation associated with cataract surgery,- reduction in risk of postoperative macular oedema associated with cataract surgery in patients with non proliferative diabetic retinopathy.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - brimonidine tartrate, quantity: 2 mg/ml; brinzolamide, quantity: 10 mg/ml - eye drops, suspension - excipient ingredients: propylene glycol; boric acid; mannitol; tyloxapol; sodium chloride; sodium hydroxide; purified water; carbomer 974p; hydrochloric acid; benzalkonium chloride - decrease of elevated intraocular pressure (iop) in adult patients with open-angle glaucoma or ocular hypertension for whom monotherapy provides insufficient iop reduction

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - latanoprost, quantity: 50 microgram/ml - eye drops, solution - excipient ingredients: dibasic sodium phosphate; sodium chloride; benzalkonium chloride; monobasic sodium phosphate monohydrate; water for injections; hydrochloric acid; sodium hydroxide - reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); latanoprost, quantity: 50 microgram/ml - eye drops, solution - excipient ingredients: dibasic sodium phosphate; water for injections; monobasic sodium phosphate monohydrate; benzalkonium chloride; sodium chloride; hydrochloric acid; sodium hydroxide - reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. xalamol 50/5 should not be used to initiate therapy.

Bandaríkin - enska - NLM (National Library of Medicine)

preferred pharmaceuticals, inc. - prednisolone acetate (unii: 8b2807733d) (prednisolone - unii:9phq9y1olm) - prednisolone acetate 10 mg in 1 ml